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ABSTRACT
Obesity in women of reproductive age is a serious concern regarding reproductive health. In many cases of infertility in 
obese women, reduction of body weight may lead to spontaneous pregnancy, without the need for more specific meth-
ods of treatment. Bariatric surgery is safe and is the most effective method for body weight reduction in obese and very 
obese patients. In practice there are two bariatric techniques; gastric banding, which leads to weight loss through intake 
restriction, and gastric bypass, leads to weight loss through food malabsorption. Gastric bypass surgery (the more frequently 
performed procedure), in most cases, leads to changes in eating habits and may result in vomiting, diarrhea and rapid body 
mass reduction. There are reliable data describing the continuous increase in the number of women who are trying to 
conceive, or are already pregnant, following bariatric surgery. Most medical specialists advise women to avoid pregnancy 
within 12–18 months after bariatric surgery. This allows for time to recover sufficiency from the decreased absorption of 
nutrients caused by the bariatric surgery. During this period there is a need for the use of reliable contraception. As there 
is a risk for malabsorption of hormones taken orally, the combined and progestogen-only pills are contraindicated, and 
displaced by non-oral hormonal contraception or non-hormonal methods, including intrauterine devices and condoms.
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INTRODUCTION
Based on research from 2003–2005, it can be assumed 
that more than 20% of Polish women suffer from obesity, 
and 2.2% of women very severe obesity [body mass index 
(BMI) > 40 kg/m2] [1]. Data from 2009 in Poland, in women 
aged over 15 years, has suggested that 15.2% of women were 
obese and 29.4% of women were overweight [2]. Higher 
percentages of obesity and overweight among women have 
been observed in studies from 2014 [3]. There are no sig-
nificant, numerical data regarding the prevalence of obesity 
for women in their reproductive years, but obesity almost 
certainly affects this population to a significant level. It is 
considered that obesity is one of the factors that prevents or 
hinders pregnancy, while it is associated with an unhappy 
motherhood in women who do achieve pregnancy [4–6]. 
Over 20% of couples in Europe wishing to conceive a child, 
need to use a form of assisted reproduction [6]. The first 
recommendation following consultation with a reproduc-
tive specialist in the clinic is typically weight reduction [7]. In 
some instances, weight loss alone results in the restoration of 
regular menstrual cycles and successful pregnancy. Medical 
literature and popular magazines provide a lot of information 
about weight loss methods. These methods are associated 
with good results in a proportion of patents. However, for 
most women with obesity or very severe obesity, conven-
tional methods of weight reduction are usually unsatisfac-
tory or ineffective. This is the reason why obese women, 
especially women with problems getting pregnant, decide 
to have bariatric surgery. Every type of bariatric surgery has 
its own characteristics and aims to reduce the absorption of 
nutrients. Weight reduction in obese women is expected, 
although limiting the absorption of some nutrients, supple-
ments and vitamins prior to pregnancy (or during pregnancy) 
may have a negative effect on the pregnancy, affecting the 
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development of the fetus and newborn. Accordingly, it is 
recommended that women should postpone pregnancy 
by at least 12 to 18 months following bariatric surgery [8, 9].
If correctional methods of weight reduction are inef-
fective, bariatric surgery is available. 
Bariatric surgery leads to good results in weight reduc-
tion in very obese women, and contributes to the reduction 
of the risk of complications such as: gestational diabetes, 
hypertension, pre-eclampsia, eclampsia, thrombosis, intrau-
terine infections, abnormal fetal development, miscarriage 
or premature births, malformations, and even excessive risk 
of infant death [10]. Furthermore, many women also get the 
chance to become pregnant naturally. In the United States 
in 1998–2005, among patients aged 18–45 years who had 
undergone bariatric methods, up to 83% were women [11, 
12]. In the years 2005–2013 in Germany, 10,330 bariatric pro-
cedures were performed, with 80% of procedures performed 
in women [13]. According to epidemiological data from Bra-
zil [14], where bariatric surgery is very popular, 78% of all bari-
atric procedures were performed in women, and the average 
age of patients was 37 years old. Similar demographic data 
has emerged from an analysis of more than 810,000 bariatric 
procedures, performed in the United States between 2002–
2011 [15], and analysis of 3,039 bariatric surgeries performed 
in the United Kingdom between 2002–2014 [16]. 
Surgeons utilise various techniques to perform bariatric 
surgery, although the ultimate goal is to achieve weight loss 
as a result of intake restriction or reduced absorption of nu-
trients (food malabsorption) [17, 18]. Techniques based on 
both of these mechanisms are also available. Treatment ap-
proaches involving food intake restriction utilise adjustable 
gastric bands or sleeve gastrectomy. For the second group 
of treatment approaches (excluding treatments), the biliary 
limb, pancreas and duodenum are excluded. The third group 
(the treatment combining both of these methods) includes 
completion of Roux-en-Y gastric bypass surgery. Restrictive 
procedures, which reduce stomach capacity and narrow the 
passage of food into the intestine, limit servings of food con-
sumed. Excluding treatments, restricting surface absorption 
in the gastrointestinal tract and reducing the transit time of 
food, reduce the absorption of nutrients (especially excess 
carbohydrates and fats). Until recently, there were no seri-
ous complications reported in the fetus and infants born to 
women after bariatric surgery. However, some data show 
cases of abnormalities resulting from neural tube defects, 
low birth weight, and even rickets in children born to women 
shortly after bariatric surgery [19]. It is generally assumed 
that there is no difference between pregnancy outcome and 
parameters of infants born to women becoming pregnant in 
the first or second year following surgery, but the majority of 
specialists in bariatric surgery maintain that in the period of 
12–18 months after surgery (it is believed that this is a period 
of fairly rapid loss of body weight) women should avoid 
becoming pregnant [8, 9, 19–21]. It is very important for 
women planning pregnancy or during pregnancy to ensure 
suitable supplementation of iron, vitamin D, calcium, folic 
acid and vitamin B12 [22–24]. Two of the most important 
laboratory tests, frequently used in obese women, are tests 
for glucose intolerance and diabetes. The results of these 
tests in women after bariatric surgery, in particular the glu-
cose tolerance test, may be misinterpreted or could lead to 
erroneous findings. The reason for this relates specifically 
to patients after Roux-en-Y gastric bypass surgery, as these 
patients experience a dumping syndrome (symptoms like 
vomiting, bloating, sweating, dizziness, palpitations, and 
sometimes diarrhea), which may distort the results of the 
glucose tolerance test. In such cases, only fasting glucose or 
the concentration of glycated hemoglobin, should be tested. 
CONTRACEPTION AND OBESITY
According to medical criteria for the selection of contra-
ceptive methods [25], obesity does not exclude the use of any 
form of contraception. Only using the combined pill raises 
some issues due to a slight increase in the risk of thrombotic 
complications of obese women (BMI ≥ 30 kg/m2), compared 
with obese women not using the combined pill. The Euro-
pean Society of Contraception [26] advises that even women 
after bariatric surgery (without exclusion or combined sur-
gery) can safely use combined pills, and patients treated by 
restrictive methods, after reaching a BMI < 30 kg/m2, should 
not use oral combined pills. However, there is limited evi-
dence that hormonal contraception is less effective in obese 
women compared to women with normal body weight. How-
ever, there are exceptions to this rule. One of them is the 
use of contraceptive patches that contain ethinyl estradiol 
and norelgestromin [27]. It is believed that the effectiveness 
of this form of contraception may be reduced in women 
weighing ≥ 90 kg. At present, there are no data on the ef-
fectiveness of the contraceptive patch, containing 0.55 mg 
ethinyl estradiol and 2.1 mg gestodene in obese women [28]. 
However, there are still quite limited data on the efficacy of 
this form of contraceptive, in women with BMI ≥ 30 kg/m2 [29]. 
Another exception is the use of emergency contraception by 
obese patients, especially those that contain 1.5 mg levonorg-
estrel [30]. In the literature there are also some reservations 
about the effectiveness of the progestogen-only pill in obese 
women [31], although poor adherence may have been the 
cause of reduced efficacy of this method. 
HORMONAL CONTRACEPTION FOR WOMEN 
AFTER EXCLUSION OR MIXED BARIATRIC 
SURGERY
As seen in Table 1, neither combination nor progesto-
gen-only pills should be used in patients after the more 
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radical (impairing absorption) bariatric surgery. For these 
patients, emergency contraception pills are also not recom-
mended. Other methods can be offered for these patients, 
including hormonal contraception in injection, implants, 
rings or patches. Although the treatment of patients after 
bariatric surgery is not performed by gynaecologists, knowl-
edge of the proper selection of contraceptive methods is 
useful for specialists in this field [32]. Furthermore, it is im-
portant that contraception is available to all patients after 
bariatric surgery, and that for women planning pregnancy, 
periodic contraception is indicated for the health of the 
fetus and newborn.
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Table 1. Proposed medical criteria for the selection of contraception in obese patients and patients following bariatric surgery
Type of contraceptive
Recommendations for patients
Obese [25] or after bariatric surgery  
(no malabsorption) After bariatric surgery with malabsorption
Contraceptive implant No contraindications No contraindications
Medroxyprogesterone in injections No contraindications No contraindications
Contraceptive patches and rings No contraindications No contraindications
Combination pills Used with caution Method not recommended unless others cannot be used
Progestogen-only pills No contraindications Method not recommended unless others cannot be used
Emergency contraception No contraindications Method not recommended unless others cannot be used
IUD (Intra Uterine Device) No contraindications No contraindications
